Most Profitable ARCA Pharmaceutical Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
144.07 B
 0.18 
 1.16 
 0.21 
2NVO Novo Nordisk AS
100.99 B
(0.10)
 2.86 
(0.29)
3RDY Dr Reddys Laboratories
55.68 B
(0.18)
 1.54 
(0.28)
4MRK Merck Company
17.13 B
(0.10)
 1.82 
(0.17)
5JNJ Johnson Johnson
14.07 B
 0.17 
 1.15 
 0.19 
6NVS Novartis AG ADR
11.94 B
 0.19 
 1.36 
 0.26 
7LLY Eli Lilly and
10.59 B
 0.06 
 2.06 
 0.11 
8AZN AstraZeneca PLC ADR
8.69 B
 0.17 
 1.16 
 0.19 
9PFE Pfizer Inc
8.05 B
(0.05)
 1.20 
(0.06)
10SNY Sanofi ADR
5.5 B
 0.14 
 1.38 
 0.20 
11ABBV AbbVie Inc
4.29 B
 0.16 
 1.40 
 0.23 
12GSK GlaxoSmithKline PLC ADR
2.95 B
 0.14 
 1.75 
 0.24 
13ZTS Zoetis Inc
2.5 B
 0.00 
 1.65 
 0.00 
14RPRX Royalty Pharma Plc
1.33 B
 0.19 
 2.06 
 0.38 
15OGN Organon Co
864 M
 0.01 
 2.79 
 0.03 
16JAZZ Jazz Pharmaceuticals PLC
560.12 M
 0.06 
 1.75 
 0.10 
17ALKS Alkermes Plc
367.07 M
 0.12 
 1.94 
 0.24 
18ELAN Elanco Animal Health
338 M
(0.09)
 2.13 
(0.20)
19PBH Prestige Brand Holdings
209.34 M
 0.07 
 2.38 
 0.16 
20BHC Bausch Health Companies
(72 M)
(0.04)
 2.86 
(0.11)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.